US weekly jobless claims rise slightly; labor market defies recession fears

By Lucia Mutikani WASHINGTON (Reuters) – The number of Americans filing new claims for unemployment benefits increased modestly last week and private employers hired more workers than expected in May, pointing to continued labor market tightness that could push the Federal Reserve to keep interest rates elevated. The labor market is slowing only marginally, keeping…

Read More

NATO squabbles over speedy accession of Ukraine as decisive summit looms

By Sabine Siebold and Gwladys Fouche OSLO (Reuters) – Moscow cannot stop Ukraine from becoming a NATO member, the alliance’s chief Jens Stoltenberg said on Thursday, as divisions among allies about the speed of Kyiv’s accession became apparent only weeks before a decisive mid-July summit in Vilnius. “All allies agree that Moscow does not have…

Read More

SpaceX’s Starlink wins Pentagon contract for satellite services to Ukraine

By Mike Stone and Joey Roulette WASHINGTON (Reuters) – SpaceX’s Starlink, the satellite communications service started by billionaire Elon Musk, now has a Department of Defense contract to buy those satellite services for Ukraine, the Pentagon said on Thursday. “We continue to work with a range of global partners to ensure Ukraine has the resilient…

Read More

U.S. Supreme Court gives boost to whistleblowers in drug pricing case

By John Kruzel WASHINGTON (Reuters) – The U.S. Supreme Court on Thursday gave a boost to whistleblowers in their bid to revive lawsuits accusing pharmacy operators of knowingly overbilling government health insurance programs for prescription drugs at taxpayers’ expense. The justices in a 9-0 decision threw out a lower court’s ruling that said the pharmacies…

Read More

AstraZeneca drug combo gets US nod to treat a type of prostate cancer

(Reuters) – AstraZeneca said on Thursday that a combination of its cancer drug Lynparza and abiraterone has been approved in the United States for the treatment of BRCA-mutated metastatic castration-resistant prostate cancer. The company said the combination treatment reduced the risk of disease progression or death by 76% compared with usage of abiraterone alone. (Reporting…

Read More

U.S. consumer outlook dims as upscale retailers, discounters slash forecasts

By Aishwarya Venugopal (Reuters) – Weak profit forecasts from department store chain Macy’s to discounter Dollar General on Thursday underscored the fragile health of the U.S. consumer as persistent inflation curbs spending. Several U.S. retailers said sales have ebbed as consumers react to higher prices for food and other essentials. Broadly, U.S. consumer spending trends…

Read More

Analysis-US debt-ceiling deal averts disaster, but savings might be less than advertised

By Andy Sullivan WASHINGTON (Reuters) – The bipartisan debt-ceiling deal that could clear Congress as soon as Thursday would stave off an imminent U.S. default, but might deliver less budget savings than Republicans have hoped for, according to nonpartisan budget analysts. The agreement ensures that President Joe Biden will not have to grapple with another…

Read More